(HealthDay)—Simvastatin/ezetimibe does not appear to be beneficial for severe alopecia areata (AA) in a sample of 20 patients, according to a letter to the editor published in the May issue of the ...
SEATTLE, Sept. 4 -- Simvastatin/ezetimibe (Vytorin) may increase the risk of cancer after all, concluded a leading American biostatistician who dismissed as prematurely reassuring an analysis by ...
The updated AHA/ACC cholesterol management guidelines recommend moderate or high intensity statin therapy in patients over 75 years old with clinical atherosclerotic cardiovascular disease. According ...